Aptevo Therapeutics Inc.APVONASDAQ

52-Week Range4-1300

3.95Current 4.671299.60

Want to monitor APVO?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

FBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm

Club Offers for Travel Enthusiasts in the U.S.

Nvidia Price Target Raised to $325: Wall Street Says $1 Trillion Blackwell Revenue Is Coming

Mag 7 Or 'Lag 7?' A Quant Review

Fastly Surges 11%: The Comeback Is Real, but Insiders Have Been Selling the Whole Way Up

Howmet Aerospace: Supply Constraints And Pricing Power Can Drive Growth

BXP Declares Regular Quarterly Dividend

ETV: Monthly Distribution And Delivering Strong Total Returns

Avanti Gold Corp. Engages ICP Securities Inc. for Automated Market Making Services

OPW Retail Fueling 71SO Segmented Overfill Prevention Valve Earns CARB EVR Certification

Metalero Closes Oversubscribed Private Placement

American Healthcare REIT Declares First Quarter 2026 Distribution

Titan International, Inc. Announces Consolidation of Tire Production to Improve Operational Efficiency of US Manufacturing

Calumet to Attend H.C. Wainwright Renewable Fuels Virtual Day

Timken Broadens Automated Lubrication Systems Capabilities with Acquisition of Bijur Delimon

Cousins Properties Announces Its First Quarter 2026 Common Stock Dividend

PREFORMED LINE PRODUCTS ANNOUNCES QUARTERLY DIVIDEND

ATN Board Declares Quarterly Dividend

Qnity Collaborates with NVIDIA to Accelerate Innovation for Semiconductor and Advanced Electronics Materials

Accelerant Announces Fourth Quarter and Full Year 2025 Results

About